Enveric Biosciences earnings were -$12.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ENVB earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$4.0M, up 19.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ENVB reported annual earnings of -$12.1M, with 26.7% growth.
Enveric Biosciences Earnings Reports & History FAQ
What were Enveric Biosciences's earnings last quarter?
Enveric Biosciences (NASDAQ: ENVB) reported Q4 2025 earnings per share (EPS) of -$0.50, up 99.14% year over year. Total ENVB earnings for the quarter were -$4.04 million. In the same quarter last year, Enveric Biosciences's earnings per share (EPS) was -$57.81.
Is Enveric Biosciences profitable or losing money?
As of the last Enveric Biosciences earnings report, Enveric Biosciences is currently losing money. Enveric Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$8.77 million, a 8.39% decrease year over year.
What was ENVB's earnings growth in the past year?
As of Enveric Biosciences's earnings date in Q2 2026, Enveric Biosciences's earnings has grown year over year. ENVB earnings in the past year totalled -$12.13 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.